Acute lymphoblastic leukaemia: open trials in Denmark

• NCT06395103

  Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

  Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC

  Rigshospitalet, Copenhagen Oe

  Registry updated 2026-10-30

• NCT07570173

  A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)

  Trial Treatment · Phase 2/3 · Merck Sharp & Dohme LLC

  Aalborg University Hospital, Aalborg · Region Midtjylland, Aarhus N · Rigshospitalet, Copenhagen Oe · Odense University Hospital, Odense C

  Registry updated 2026-10-30

• NCT06367725

  Pharmacokinetics of Dexamethasone in Childhood ALL and Reduction in Bone Mineral Density

  Research · University of Aarhus

  Department of Paediatrics and Adolescent Medicine, Aalborg University Hospital, Aalborg · Department of Paediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus N · Department of Paediatrics and Adolescent Medicine, Copenhagen University Hospital Rigshospitalet, Copenhagen · Department of Paediatrics and Adolescent Medicine, Odense University Hospital, Odense

  Registry updated 2026-10-26

• NCT07476729

  International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)

  Trial Treatment · Phase 3 · Charite University, Berlin, Germany

  Region Midtjylland, Aarhus N · Rigshospitalet, Copenhagen Oe · Odense University Hospital, Odense C

  Registry updated 2026-10-26

• NCT07155226

  Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression

  Trial Treatment · Phase 1/2 · AstraZeneca

  Rigshospitalet, Copenhagen Oe

  Registry updated 2026-10-23

• NCT07297914

  Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL

  Trial Treatment · Phase 2/3 · Bambino Gesù Hospital and Research Institute

  Rigshopsitalet, University Hospital, Copenhagen

  Registry updated 2026-10-20

• NCT05327894

  Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia

  Trial Treatment · Phase 3 · Princess Maxima Center for Pediatric Oncology

  Aarhus University, Aarhus N · Rigshospitalet, Copenhagen Oe · Odense University Hospital, Odense C

  Registry updated 2026-10-19

• NCT07648264

  Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

  Trial Treatment · Phase 3 · CSL Behring

  Rigshospitalet, Copenhagen · Zealand University Hospital, Roskilde · Department of Medicine, Vejle Hospital, Vejle

  Registry updated 2026-10-14

• 2025-522019-40-00

  Study of the safety and efficacy of asciminib in pediatric and young adult participants with r/r Ph+ or ABL-class Ph-like ALL

  Trial Treatment · Phase 1/2 · Novartis Pharma AG

  Rigshospitalet, Copenhagen Oe

  Registry updated 2026-10-06

• NCT05748171

  A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL

  Trial Treatment · Phase 2 · Pfizer

  Rigshospitalet, Copenhagen Oe

  Registry updated 2026-09-24

• NCT01949129

  Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia

  Trial Treatment · Phase 2/3 · St. Anna Kinderkrebsforschung

  Rigshospitalet, Copenhagen Oe

  Registry updated 2026-09-04

• NCT07780123

  Nurture by Nature Feasibility Study

  Trial Treatment · Ina Olmer Specht

  Bispebjerg and Frederiksberg Hospital, The Parker Institute, Frederiksberg

  Registry updated 2026-09-01

• NCT03911128

  A Treatment Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia

  Research · Mats Heyman

  Aalborg University Hospital, Dept of Paediatrics, Aalborg · Aarhus University Hospital, Child and Adolescent Health, Aarhus · Aarhus University Hospital, Aarhus · Rigshospitalet, Dept of Paediatrics, Copenhagen · Rigshospitalet, Dept of Haematology, Copenhagen · Odense University Hospital, Dept of Paediatrics, Odense

  Registry updated 2026-08-13

• NCT04307576

  A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia

  Trial Treatment · Phase 3 · Mats Heyman

  Aalborg University Hospital, Aalborg · Aarhus Universitetshospital, Aarhus N · Region Midtjylland, Aarhus N · Rigshospitalet, Copenhagen Oe · Odense University Hospital, Odense C

  Registry updated 2026-08-12

• NCT04877522

  Asciminib Roll-over Study

  Trial Treatment · Phase 4 · Novartis Pharmaceuticals

  Rigshospitalet, Copenhagen Oe

  Registry updated 2026-07-06

• 2023-504694-20-00

  Inotuzumab ozogamicin for Acute Lymphoblastic Leukemia

  Trial Treatment · Phase 1/2 · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

  Rigshospitalet, Copenhagen Oe

  Registry updated 2026-06-04

• 2025-520982-39-00

  Study on chemotherapy and experimental drugs in patients with Philadelphia Chromosome positive and ABL-class Philadelphia Chromosome-Like B-cell Acute Lymphoblastic Leukemia

  Trial Treatment · Phase 3 · Universita Degli Studi Di Milano Bicocca

  Aarhus University Hospital, Aarhus N · Rigshospitalet, Copenhagen Oe · Odense University Hospital, Odense C · Zealand University Hospital, Roskilde

  Registry updated 2026-05-08

• NCT07499349

  Establishment of a Phamacokinetik Model for Erwinase Pharmacokinetiks: The Aim of This Sub Study is to Optimize Target Trough Attainment While Minimizing High Exposures That Impose Increased Risk of Side Effects Such as Hyperammonemia

  Research · Aarhus University Hospital

  Aarhus University Hospital, Aarhus

  Registry updated 2026-04-15

• NCT03590171

  International Study for Treatment of High Risk Childhood Relapsed ALL 2010

  Trial Treatment · Phase 2 · Charite University, Berlin, Germany

  Copenhagen University Hospital, Rigshospitalet, Copenhagen

  Registry updated 2026-03-17

• NCT05658640

  HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies

  Trial Treatment · Phase 1/2 · Princess Maxima Center for Pediatric Oncology

  Rigshospitalet, Copenhagen Oe

  Registry updated 2025-09-16

• NCT05745714

  HEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies

  Trial Treatment · Phase 1/2 · Princess Maxima Center for Pediatric Oncology

  Rigshospitalet, Copenhagen Oe

  Registry updated 2025-09-16

• NCT05751044

  HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies

  Trial Treatment · Phase 1/2 · Princess Maxima Center for Pediatric Oncology

  Rigshospitalet, Copenhagen Oe

  Registry updated 2025-09-16

• NCT04209244

  Effect of Fish Oil on Hyperlipidemia and Toxicities in Children and Young Adults With Acute Lymphoblastic Leukemia

  Trial Treatment · Copenhagen University Hospital, Rigshospitalet

  Aalborg University Hospital, Aalborg · Aarhus University Hospital, Aarhus · Rigshospitalet, Copenhagen · Odense University Hospital, Odense

  Registry updated 2019-12-26

All Acute lymphoblastic leukaemia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error